Results

Total Results: 409 records

Showing results for "author year description".

101. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/JcwfLrEqaaxP6DPEQvxgUs
     February 18, 2020 - Editorial pages 1977, 1979 and 1981 Author Audio Interview, Author Video Interview, Animated Summary … CME Quiz at jamanetworkcme.com Related articles at jamacardiology.com, jamainternalmedicine.com Author … Corresponding Author: Kirsten Bibbins-Domingo, PhD, MD, MAS (chair@uspstf.net). … USPSTF Levels of Certainty Regarding Net Benefit Level of Certainty Description High The available … Author Contributions: Dr Bibbins-Domingo had full access to all of the data in the study and takes responsibility

102. Archived: Final Evidence Review: Asymptomatic Bacteriuria in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review11/asymptomatic-bacteriuria-in-adults-screening-2008
     July 15, 2008 - July 2008 Prepared by: Kenneth Lin, MD, and Kevin Fajardo, MD, MPH, MTMH Corresponding Author … [D] Select for Text Description … Bacteriuria Author … , Year (Reference) Study Design Sample Characteristics Intervention and/or Comparison

103. Screening for Skin Cancer: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/YFZy6kszQPq5tNGdZC25XC
     July 26, 2016 - JAMA. 2016;316(4):429-435. doi:10.1001/jama.2016.8465 Editorial page 398 Author Audio Interview at … Corresponding Author: Kirsten Bibbins-Domingo, PhD, MD, MAS (chair@uspstf.net). … USPSTF Levels of Certainty Regarding Net Benefit Level of Certainty Description High The available … 0.5 0 1994 1996 1998 2000 2012 M el an om a M or ta lit y pe r 1 00 0 00 P er so ns Year … After a 2-year public skin cancer awareness campaign, 360 288 adults 20 years and older (about 19% of

104. Archived: Final Evidence Summary: Speech and Language Delay in Preschool Children: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary47/speech-and-language-delay-in-preschool-children-screening-2006
     February 15, 2006 - Author Affiliations All Oregon Health and Science University, Portland, Oregon. … Questions Text Description … Old   Author … A study of language development in a sample of 3 year old children. … Risk factors for speech delay of unknown origin in 3-year-old children.

105. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/by8VJVre6h6BmadrGxaFMM
     April 01, 2016 - Preventive Services Task Force* Description: Update of the 2009 USPSTF recommendation on aspirin use … (I statement) Ann Intern Med. doi:10.7326/M16-0577 www.annals.org For author affiliation, see end of … The magni- tude of benefit varies by age and 10-year CVD risk. … Results were stratified by age decade, sex, and 10-year CVD risk. … USPSTF Levels of Certainty Regarding Net Benefit Level of Certainty* Description High The available

106. Screening for Colorectal Cancer: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/n4sdjxShTApRE6UxvyYuzG
     November 01, 2008 - Preventive Services Task Force* Description: Update of the 2002 U.S. … (I statement) Ann Intern Med. 2008;149:627-637. www.annals.org For author affiliation, see end of text … See Table 1 for a description of the USPSTF grades and Table 2 for a description of the USPSTF classification … average in one model and a 22-year average in the other. … Preventive Services Task Force Levels of Certainty Regarding Net Benefit Level of Certainty* Description

107. Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/gXnmnkofo8FxoLnCmXJDjb
     October 01, 2009 - Preventive Services Task Force Description: New recommendation from the U.S. … Ann Intern Med. 2009;151:474-482. www.annals.org For author affiliation, see end of text. … See Table 1 for a description of the USPSTF grades and Table 2 for a description of the USPSTF classification … with untreated hypertension or a 60-year-old female with untreated hyper- tension and hyperlipidemia … USPSTF Levels of Certainty Regarding Net Benefit Level of Certainty* Description High The available

108. Behavioral Counseling to Prevent Skin Cancer: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/5UgQm-zskVEKmcVnczHxGY
     July 01, 2012 - Preventive Services Task Force* Description: Update of the 2003 U.S. … Ann Intern Med. 2012;157:59-65. www.annals.org For author affiliation, see end of text. * For a list … common type of cancer in the United States and is diagnosed in more than 2 million Americans each year … Levels of Certainty Regarding Net Benefit* Level of Certainty Description High The available evidence … Ten-year follow-up of secondary study outcomes revealed a decreased risk for invasive melanoma (RR, 0.27

109. untitled (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/QWUmLEKdwcYA-AKGp5dNaQ
     August 09, 2016 - (I statement) JAMA. 2016;316(6):625-633. doi:10.1001/jama.2016.9852 Editorial page 589 Author Audio … jamanetworkcme.com Related articles at jamacardiology.com jamainternalmedicine.com jamapediatrics.com Author … Corresponding Author: Kirsten Bibbins-Domingo, PhD, MD, MAS (chair@uspstf.net). … USPSTF Levels of Certainty Regarding Net Benefit Level of Certainty Description High The available … The study was a 10-year cohort follow-up of a 2-year trial of pravastatin followed by continued statin

110. Screening for Chronic Obstructive Pulmonary Disease Using Spirometry: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/QTJe7MfZ7cru9yYpxqx77m
     April 01, 2008 - Preventive Services Task Force* Description: New U.S. … (Grade D recommendation) Ann Intern Med. 2008;148:529-534. www.annals.org For author affiliations, see … Preventive Services Task Force Levels of Certainty Regarding Net Benefit Level of Certainty* Description

111. Ykjvkfmv5Jf8Bl3Rbx8Bp7 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ykjVKfmV5Jf8bL3rBx8BP7
     December 01, 2015 - Preventive Services Task Force Description: Update of the 2008 U.S. … (B recommendation) Ann Intern Med. 2015;163:861-868. doi:10.7326/M15-2345 www.annals.org For author … The hazard ratio (HR) for all-cause mortality at 10-year follow-up was 1.06 (95% CI, 0.90 to 1.25). … However, by 23- year follow-up, the Chinese trial found decreased risk for cardiovascular mortality ( … USPSTF Levels of Certainty Regarding Net Benefit Level of Certainty* Description High The available

112. Screening for Postmenopausal Osteoporosis: A Summary of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/2kM7LY6ccceVo8bmdUXhYm
     September 01, 2002 - for Postmenopausal Osteoporosis 223 Screening for Postm enopausal O steoporosis 224 Quality Author … risk factors assessment (continued) Screening for Postm enopausal O steoporosis 226 Quality Author … The FIT-II is the largest study and provided the most detailed description of recruitment and results … It is not clear from this description how many patients did not meet the eligibility criteria. … Screening for Postmenopausal Osteoporosis 229 Duration Age Exclusion Lost to Author (years) (years)

113. Archived: Evidence Summary: Aspirin: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
     March 15, 2007 - A large, 6-year, fair-quality cohort study 28  of adults treated with various aspirin doses found that … Notes Author Affiliation a. Drs. … //Slide down text description when text description is clicked $(document).ready(function(){ $('.cd-collapse … click(function(){ $(this).parent().next('.cd-collapse').slideToggle(1200); }); }); Text Description … Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC

114. Tagauj5Qoarfv3M8Fapbon (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/TAgAUJ5QoaRfV3M8fApBoN
     June 03, 2019 - Ann Intern Med. 2002;137:347-360. www.annals.org For author affiliations, see end of text. … RESULTS Description of Trials The eight randomized trials of mammography identi- fied in our review … We found several limitations of this trial, including inadequate description of allocation concealment … 20) Edinburgh (18) Gothenburg (14, 23) Stockholm (17) Malmö (15) Swedish Two- County Trial (16) Description … Current Author Addresses: Drs. Humphrey and Helfand and Mr.

115. Evidence Summary: Vision in Children Ages 6 Months to 5 Years: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/vision-in-children-ages-6-months-to-5-years-screening
     September 05, 2017 - Thus, the review may have included some studies that would not meet eligibility criteria if additional description … Random Dot E stereotest: testability and reliability in 3- to 5-year-old children.  … Text Description . … Text Description . … Category Screening Test Description

116. Archived: Final Evidence Summary: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary23/diabetes-mellitus-type-2-in-adults-screening-2008
     June 15, 2008 - Corresponding Author: Susan L. … Text Description . … Diabetes incidence in lifestyle trials (Text Description) Study, Year (Reference) Follow-up, … in drug trials Text Description … Diabetes incidence in drug trials (Text Description) Study, Year (Reference) Drug Follow-up

117. Archived: Final Evidence Summary: Depression in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary21/depression-in-children-and-adolescents-screening-2009
     March 15, 2009 - Only 2 psychotherapy trials included 9- or 10-year-olds, and no completed trials included children aged … Prevalence of DSM-III-R and ICD-10 psychiatric disorders in a Spanish population of 18-year-olds. … adolescents (KQ4) Text Description … disorder (MDD) (KQ5) Text Description … addresses an appropriate and clearly focused question Standard appraisal of included studies A description

118. N3Veybr4Zdhzfqsw3Erlhe (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/N3VeYbr4ZdhZfqsw3ErLHE
     November 01, 2014 - Preventive Services Task Force* Description: Update of the 2007 U.S. … (D recommendation) Ann Intern Med. 2014;161:356-362. doi:10.7326/M14-1333 www.annals.org For author … Kong X, Mansfield A, Marro J, et al; Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. 10-year … USPSTF Levels of Certainty Regarding Net Benefit Level of Certainty* Description High The available

119. Zyao53-Sqrb6Ozzkzdmjjt (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZYao53-sqRb6oZzKzDmjjt
     December 01, 2003 - Recruitment for an intervention study and a selected description of the obese state. … The Swedish Adjustable Gastric Banding (SAGB) for morbid obesity: 9 year experience and a 4-year follow-up … Interventions for Obesity in Adults: Summary of the Evidence for the USPSTF Counseling and Behavioral Description … Interventions for Obesity in Adults: Summary of the Evidence for the USPSTF Counseling and Behavioral Description … Interventions for Obesity in Adults: Summary of the Evidence for the USPSTF Counseling and Behavioral Description

120. Archived: Evidence Summary: Bleeding Risks With Aspirin Use: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - of 40 years or older that evaluated regular oral aspirin use (≥75 mg at least every other day) for 1 year … Text Description . … § Year event rate ratio. ǁ Incidence rate ratio. … Text Description . … Data from reference. 22 § Per year. ǁ Mean of systolic and diastolic BPs combined.